Amnestic MCI Patients’ Perspectives toward Disclosure of Amyloid PET Results in a Research Context

被引：0
|
作者：
Gwendolien Vanderschaeghe
Jolien Schaeverbeke
Rik Vandenberghe
Kris Dierickx
机构：
[1] KU Leuven,Centre for Biomedical Ethics and Law, Department of Public Health and Primary Care
[2] KU Leuven,Laboratory for Cognitive Neurology, Department of Neurosciences
[3] Alzheimer Research Centre KU Leuven,Memory Clinic / Neurology
[4] Leuven research Institute for Neurodegenerative Disorders,undefined
[5] University Hospitals Leuven (UZ Leuven,undefined
[6] Campus Gasthuisberg),undefined
来源：
Neuroethics | 2017年 / 10卷
关键词：
Ethics; Amnestic MCI; Clinical trial; Qualitative research; Disclosure of return of results; Individual research results; Biomarker; Amyloid PET; Belgium;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：281 / 297
页数：16
相关论文
共 50 条
  • [41] Does Venue of HIV Testing and Results Disclosure in the Context of a Research Study Affect Adolescent Health and Behavior? Results from a Study in Western Kenya
    Luseno, Winnie Kavulani
    Field, Samuel H.
    Iritani, Bonita J.
    Odongo, Fredrick S.
    Kwaro, Daniel
    Rennie, Stuart
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, 19 (06)
  • [42] CSF Beta-Amyloid and APOE E4 Related Decline in Episodic Memory over 12 months measured using the CANTAB in individuals with amnestic MCI: Results from the European-ADNI study
    Nathan, Pradeep J.
    Abbott, Rosemary
    Lim, Yen Ying
    Galluzzi, Samantha
    Marizzoni, Moira
    Bagnoli, Cristina
    Babiloni, Claudio
    Bartres-Faz, David
    Bordet, Regis
    Didic, Mira
    Farotti, Lucia
    Forloni, Gianluigi
    Jovicich, Jorge
    Marra, Camillo
    Molinuevo, Jose Luis
    Nobili, Flavio
    Pariente, Jeremie
    Parnetti, Lucilla
    Payoux, Pierre
    Ranjeva, Jean-Philippe
    Rossini, Paolo Maria
    Schonknecht, Peter
    Hensch, Tilman
    Soricelli, Andrea
    Tsolaki, Magda
    Visser, Pieter Jelle
    Wiltfang, Jens
    Blin, Olivier
    Frisoni, Giovanni B.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2016, 19 : 264 - 264
  • [43] Clinical Significance of the Plasma Biomarker Panels in Amyloid-Negative and Tau PET-Positive Amnestic Patients: Comparisons with Alzheimer's Disease and Unimpaired Cognitive Controls
    Chang, Hsin-, I
    Huang, Kuo-Lun
    Huang, Chung-Gue
    Huang, Chi-Wei
    Huang, Shu-Hua
    Lin, Kun-Ju
    Chang, Chiung-Chih
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (11)
  • [44] Communication of Clinically Useful Next-Generation Sequencing Results to At-Risk Relatives of Deceased Research Participants: Toward Active Disclosure?
    Battistuzzi, Linda
    Ciliberti, Rosagemma
    Bruno, William
    Turchetti, Daniela
    Varesco, Liliana
    De Stefano, Francesco
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (32) : 4164 - 4165
  • [45] Correlation Between Amyloid PET Imaging and Discordant Cerebrospinal Fluid Biomarkers Results in Patients with Suspected Alzheimer's Disease
    Lojo-Ramirez, Jose Antonio
    Guerra-Gomez, Miriam
    Marin-Cabanas, Alba Marta
    Fernandez-Rodriguez, Paula
    Sanchez-Arjona, Maria Bernal
    Franco-Macias, Emilio
    Garcia-Solis, David
    JOURNAL OF ALZHEIMERS DISEASE, 2024, 97 (01) : 447 - 458
  • [46] Searching for Correlations Between Results of Psychological Tests and FDG-PET as Well as Spectroscopic Metabolites From Posterior Cingulate Gyrus in Patients with MCI.
    Zimny, A.
    Szczesniak, D.
    Wojtynska, R.
    Trypka, E.
    Bladowska, J.
    Sasiadek, M.
    EUROPEAN PSYCHIATRY, 2015, 30
  • [47] Long-term follow-up of amyloid brain deposition assessed by 11C-PIB-PET/CT in patients with amnestic mild cognitive impairment: preliminary experience
    Jimenez-Bonilla, J. F.
    Quirce, R.
    De Arcocha-Torres, M.
    Martinez-Rodriguez, I.
    Martinez-Amador, N.
    Sanchez-Juan, P.
    Rodriguez-Rodriguez, E.
    Gomez-de la Fuente, F.
    Lavado-Perez, C.
    Lucas-Velazquez, B.
    Molina-Mendoza, G.
    Cuenca-Vera, O.
    Banzo, I.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S389 - S389
  • [48] Communication of Clinically Useful Next-Generation Sequencing Results to At-Risk Relatives of Deceased Research Participants: Toward Active Disclosure? Reply
    Lolkema, Martijn P.
    Gadellaa-vanHooijdonk, Christa G.
    Bredenoord, Annelien L.
    Voest, Emile E.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (32) : 4165 - 4166
  • [49] How Accurately Do Patients and Their Care Partners Report Results of Amyloid-β PET Scans for Alzheimer's Disease Assessment?
    James, Hailey J.
    Van Houtven, Courtney Harold
    Lippmann, Steven
    Burke, James R.
    Shepherd-Banigan, Megan
    Belanger, Emmanuelle
    Wetle, Terrie Fox
    Plassman, Brenda L.
    JOURNAL OF ALZHEIMERS DISEASE, 2020, 74 (02) : 625 - 636
  • [50] Brain amyloid load assessed by 11C-PIB PET/CT for predicting long-term severity of cognitive impairment in patients with amnestic mild cognitive impairment. A comparison with 18F-FDG PET/CT scan
    Jimenez-Bonilla, J.
    Quirce, R.
    De Arcocha-Torres, M.
    Martinez-Rodriguez, I.
    Lopez-Garcia, S.
    Lage, C.
    Garcia, M.
    Pozueta, A.
    Rodriguez-Rodriguez, E.
    Sanchez-Juan, P.
    Sanchez-Salmon, A.
    Martinez-Amador, N.
    Ruiz-Llama, S.
    Molina, G.
    Cuenca-Vera, O.
    Andres, J.
    Gutierrez-Gonzalez, A.
    Banzo, I.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S518 - S519
12345